Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 3.782.822.952.812.26

What is the latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS is 3.78 based on Mar2024 Standalone results.
Year Working Capital/Sales
Mar20243.78
Mar20232.82
Mar20222.95
Mar20212.81
Mar20202.26

How is Working Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 3.78
34.04
Mar2023 2.82
-4.41
Mar2022 2.95
4.98
Mar2021 2.81
24.34
Mar2020 2.26 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹182.3 Cr 7.3% 5.3% -23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

7.3%

5.3%

-23.2%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses